We are thrilled to share that our CEO, Ted Eveleth, will be taking the stage at NewYorkBIO's Mini Pitch Day event on November 16th from 1:40–2:00 PM. This highly anticipated event will bring together New York's bioscience leaders, fostering an environment of innovation and collaboration.
A Preview of Insight and Innovation
NewYorkBIO, a prominent organization supporting the growth of New York State’s life science industry, will be hosting the Mini Pitch Day event for early-stage life science and biotech companies. The event, scheduled to be held at JLABs in New York City, will provide a platform for select companies to pitch their ideas to a panel of judges, receiving real-time feedback on their presentations. The curated audience will consist of service providers, entrepreneurs, and industry leaders, emphasizing mentorship and encouraging investor presence.
AvantGuard's Anticipated Presence
AvantGuard, a pioneering company, is on the brink of revolutionizing the landscape of antimicrobial solutions. Blurring the lines between antibiotics, antiseptics, and disinfectants, we are creating innovative products that manage surfaces, including skin, and provide long-term protection against viruses, bacteria, and fungi/mold. Our proprietary combinations of specialty molecules and polymers are customized to offer prolonged antimicrobial efficacy to a wide range of surfaces and materials. This endeavor represents a $60 billion opportunity and is critical to ensuring a healthier and safer world for all.